These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34991591)

  • 1. Assessing the impact of the Good Samaritan Law in the state of Connecticut: a system dynamics approach.
    Sabounchi NS; Heckmann R; D'Onofrio G; Walker J; Heimer R
    Health Res Policy Syst; 2022 Jan; 20(1):5. PubMed ID: 34991591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using qualitative system dynamics modeling to understand overdose bystander behavior in the context of Connecticut's Good Samaritan Laws and identify effective policy options.
    Thompson RL; Sabounchi NS; Ali SS; Heimer R; D'Onofrio G; Heckmann R
    Harm Reduct J; 2024 Jun; 21(1):124. PubMed ID: 38937759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good Samaritan laws and overdose mortality in the United States in the fentanyl era.
    Hamilton L; Davis CS; Kravitz-Wirtz N; Ponicki W; Cerdá M
    Int J Drug Policy; 2021 Nov; 97():103294. PubMed ID: 34091394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effectiveness of New York's 911 Good Samaritan Law-Evidence from a natural experiment.
    Nguyen H; Parker BR
    Int J Drug Policy; 2018 Aug; 58():149-156. PubMed ID: 29966919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Caught with a body" yet protected by law? Calling 911 for opioid overdose in the context of the Good Samaritan Law.
    Latimore AD; Bergstein RS
    Int J Drug Policy; 2017 Dec; 50():82-89. PubMed ID: 29040841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways to racial disparities in the effects of Good Samaritan Laws: A mixed methods pilot study.
    Pamplin JR; King C; Cooper C; Bennett AS; Elliott L; Davis CS; Rouhani S; Townsend TN
    Drug Alcohol Depend; 2023 Aug; 249():110823. PubMed ID: 37336006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of drug-related Good Samaritan laws: A review of the literature.
    Moallef S; Hayashi K
    Int J Drug Policy; 2021 Apr; 90():102773. PubMed ID: 32467017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-overdose laws association with opioid use and overdose mortality.
    McClellan C; Lambdin BH; Ali MM; Mutter R; Davis CS; Wheeler E; Pemberton M; Kral AH
    Addict Behav; 2018 Nov; 86():90-95. PubMed ID: 29610001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of the 911 Good Samaritan Law and 911-calling behavior of overdose witnesses.
    Jakubowski A; Kunins HV; Huxley-Reicher Z; Siegler A
    Subst Abus; 2018; 39(2):233-238. PubMed ID: 28972445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey findings on law enforcement agency drug response practices, overdose victim outcomes, and Good Samaritan Laws.
    Richardson NJ; Ray B; Smiley-McDonald HM; Davis CS; Kral AH
    Drug Alcohol Depend; 2023 Jul; 248():109916. PubMed ID: 37236060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A drug-related Good Samaritan Law and calling emergency medical services for drug overdoses in a Canadian setting.
    Moallef S; Choi J; Milloy MJ; DeBeck K; Kerr T; Hayashi K
    Harm Reduct J; 2021 Aug; 18(1):91. PubMed ID: 34446026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review and inventory of 911 Good Samaritan Law Provisions in the United States.
    Reader SW; Walton GH; Linder SH
    Int J Drug Policy; 2022 Dec; 110():103896. PubMed ID: 36343430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Law enforcement attitudes toward overdose prevention and response.
    Green TC; Zaller N; Palacios WR; Bowman SE; Ray M; Heimer R; Case P
    Drug Alcohol Depend; 2013 Dec; 133(2):677-84. PubMed ID: 24051061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an Inverted Synthetic Control Method to Estimate Effects of Recent Drug Overdose Good Samaritan Laws, Overall and by Black/White Race/Ethnicity.
    Townsend TN; Hamilton LK; Rivera-Aguirre A; Davis CS; Pamplin JR; Kline D; Rudolph KE; Cerdá M
    Am J Epidemiol; 2022 Sep; 191(10):1783-1791. PubMed ID: 35872589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research to law: A qualitative study of Massachusetts' 2018 Care Act expanding emergency department initiation of medication for opioid use disorder.
    Alinsky RH; Silva C; Adger H; McGinty EE
    J Subst Abuse Treat; 2022 Oct; 141():108803. PubMed ID: 35599095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dynamic model of the opioid drug epidemic with implications for policy.
    Homer J; Wakeland W
    Am J Drug Alcohol Abuse; 2021 Jan; 47(1):5-15. PubMed ID: 32515234
    [No Abstract]   [Full Text] [Related]  

  • 17. Bleeding Control Protections Within US Good Samaritan Laws.
    Levy MJ; Wend CM; Flemming WP; Lazieh A; Rosenblum AJ; Pineda CM; Wolfberg DM; Jenkins JL; Goolsby CA; Margolis AM
    Prehosp Disaster Med; 2024 Apr; 39(2):156-162. PubMed ID: 38572644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing landscape of naloxone availability in the United States, 2011 - 2017.
    Freeman PR; Hankosky ER; Lofwall MR; Talbert JC
    Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
    Davis CS; Carr D
    Drug Alcohol Depend; 2015 Dec; 157():112-20. PubMed ID: 26507172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.
    Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC
    JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.